TLGT - Teligent, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.27
-0.08 (-2.39%)
As of 11:43AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close3.35
Open3.39
Bid3.30 x 800
Ask3.31 x 800
Day's Range3.25 - 3.46
52 Week Range2.43 - 6.68
Volume134,571
Avg. Volume336,532
Market Cap175.069M
Beta (3Y Monthly)0.16
PE Ratio (TTM)N/A
EPS (TTM)-0.76
Earnings DateJul 28, 2017 - Jul 31, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Trade prices are not sourced from all markets
  • GlobeNewswire3 hours ago

    Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05%

    BUENA, N.J., Oct. 17, 2018 -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the.

  • Simply Wall St.6 days ago

    What You Must Know About Teligent Inc’s (NASDAQ:TLGT) Market Risks

    If you own shares in Teligent Inc (NASDAQ:TLGT) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of Read More...

  • GlobeNewswire15 days ago

    Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05%

    Teligent, Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Fluocinonide Ointment USP, 0.05%.  This is Teligent’s tenth approval for 2018, and its twenty-ninth approval from its internally-developed pipeline of topical generic pharmaceutical medicines.

  • Is the Options Market Predicting a Spike in Teligent (TLGT) Stock?
    Zacks21 days ago

    Is the Options Market Predicting a Spike in Teligent (TLGT) Stock?

    Investors need to pay close attention to Teligent (TLGT) stock based on the movements in the options market lately.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of TLGT earnings conference call or presentation 8-Aug-18 8:30pm GMT

    Q2 2018 Teligent Inc Earnings Call

  • GlobeNewswire2 months ago

    Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage

    Teligent, Inc. (TLGT) (“Teligent”), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride crisis by securing inventory to cover 100% of the Canadian Market following a breakdown in the global supply chain. The hurricanes that hit Puerto Rico this past fall damaged one of the largest sterile water and sodium chloride supplier’s manufacturing plants, crippling supply and causing significant worldwide drug shortages. Sterile water and sodium chloride are essential components in the mixing of medications for injection.

  • Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage
    CNW Group2 months ago

    Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage

    TORONTO , Aug. 14, 2018 /CNW/ - Teligent, Inc. (TLGT) ("Teligent"), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride crisis by securing inventory to cover 100% of the Canadian Market following a breakdown in the global supply chain. The hurricanes that hit Puerto Rico this past fall damaged one of the largest sterile water and sodium chloride supplier's manufacturing plants, crippling supply and causing significant worldwide drug shortages. Sterile water and sodium chloride are essential components in the mixing of medications for injection.

  • Benzinga2 months ago

    The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 8) AstraZeneca plc (ADR) (NYSE: AZN ) Bio-Rad Laboratories, Inc. ...

  • Teligent (TLGT) Reports Q2 Loss, Tops Revenue Estimates
    Zacks2 months ago

    Teligent (TLGT) Reports Q2 Loss, Tops Revenue Estimates

    Teligent (TLGT) delivered earnings and revenue surprises of -1900.00% and 4.34%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    Teligent: 2Q Earnings Snapshot

    The Buena, New Jersey-based company said it had a loss of 39 cents per share. Losses, adjusted to extinguish debt, were 20 cents per share. The specialty generic pharmaceutical company posted revenue of ...

  • GlobeNewswire2 months ago

    Teligent, Inc. Announces Second Quarter 2018 Results

    BUENA, N.J., Aug. 08, 2018-- Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2018.. The Company ...

  • ACCESSWIRE2 months ago

    Teligent, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Teligent, Inc. (NASDAQ: TLGT ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time. ...

  • TEVA vs. TLGT: Which Stock Is the Better Value Option?
    Zacks2 months ago

    TEVA vs. TLGT: Which Stock Is the Better Value Option?

    TEVA vs. TLGT: Which Stock Is the Better Value Option?

  • GlobeNewswire2 months ago

    Teligent, Inc. to Hold Conference Call for Second Quarter 2018 Results

    BUENA, N.J., Aug. 03, 2018-- Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Wednesday August 8, 2018 to discuss ...

  • GlobeNewswire3 months ago

    Teligent, Inc. Announces FDA Approval of Hydrocortisone Lotion USP, 2.5%

    Teligent, Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Hydrocortisone Lotion USP, 2.5%.  This is Teligent’s ninth approval for 2018, and its twenty-eighth approval from its internally-developed pipeline of topical generic pharmaceutical medicines.

  • GlobeNewswire3 months ago

    Teligent, Inc. Announces FDA Approval of Hydrocortisone Cream USP, 2.5%

    Teligent, Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Hydrocortisone Cream USP, 2.5%.  This is Teligent’s eighth approval for 2018, and its twenty-seventh approval from its internally-developed pipeline of topical generic pharmaceutical medicines.

  • AGN or TLGT: Which Is the Better Value Stock Right Now?
    Zacks3 months ago

    AGN or TLGT: Which Is the Better Value Stock Right Now?

    AGN vs. TLGT: Which Stock Is the Better Value Option?

  • AGN vs. TLGT: Which Stock Should Value Investors Buy Now?
    Zacks3 months ago

    AGN vs. TLGT: Which Stock Should Value Investors Buy Now?

    AGN vs. TLGT: Which Stock Is the Better Value Option?

  • CNW Group3 months ago

    Pure Global Cannabis Inc. completes reverse takeover transaction with PureSinse Inc.

    TORONTO , July 10, 2018 /CNW/ - Pure Global Cannabis Inc. (TSXV:PURE.V) (the "Company" or "Pure Global") (formerly Royal Sapphire Corp. (RSL.V) ("RS") is pleased to announce the completion of its previously announced amalgamation and reverse takeover transaction (the "Transaction") with PureSinse Inc. ("PureSinse").

  • ACCESSWIRE4 months ago

    Breakfast Technical Briefing on Tesaro and Three Other Additional Biotech Stocks

    LONDON, UK / ACCESSWIRE / June 20, 2018 / If you want a free Stock Review on TSRO sign up now at www.wallstequities.com/registration. Markets served include medical, agricultural, environmental, and industrial.Ahead of today's trading session, WallStEquities.com observes Teligent Inc. (NASDAQ: TLGT), Tesaro Inc. (NASDAQ: TSRO), Vascular Biogenics Ltd (NASDAQ: VBLT), and VistaGen Therapeutics Inc. (NASDAQ: VTGN).

  • Why Teligent Rose ~10.4% Yesterday
    Market Realist4 months ago

    Why Teligent Rose ~10.4% Yesterday

    On June 14, Teligent (TLGT) stock rose ~10.4% on the news of the FDA approval of its diflorasone diacetate ointment 0.05%. Investors were pleased with the news, and TLGT stock soared more than 10%. Teligent plans to launch the product in the third quarter of 2018.

  • Benzinga4 months ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Teligent Inc (NASDAQ: TLGT ) stock was trading higher ...